Pharmaceutical industry use of key opinion leaders to market prescription opioids: A review of internal industry documents.

ABSTRACT:

Objective

Prescription opioid-related deaths increased by 200 % from 2000 to 2014. There has been limited research regarding channels used by pharmaceutical companies to market prescription opioids. In this study, we investigated pharmaceutical industry use of key opinion leaders (KOLs).

Methods

We conducted a retrospective qualitative review of the first 503 opioid industry documents publicly released, which are held at the University of California, San Francisco Opioid Industry Document Archive (OIDA). We reviewed documents including legal rulings, correspondences, witness statements, clinical studies, and corporate communications for relevance and coded them by themes.

Results

Between 2001 and 2019, pharmaceutical companies including Janssen, Purdue Pharma, and Cep

SUBMITTER: Gac B 

PROVIDER: S-EPMC11647219 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature